Will DeLoache

Company: Novome Biotechnologies

Job title: Co-Founder & CEO

Seminars:

Genetically Engineered Microbial Medicines (GEMMs) for the Treatment of Chronic Diseases 12:00 pm

Novome has developed a suite of synthetic biology tools for engineering highly abundant gut commensal microbes Establishing an exclusive niche through rare carbohydrate utilization enables robust and controllable engraftment of GEMMs in the gastrointestina l tract The company’s lead asset is a GEMM designed to treat hyperoxaluria and prevent recurrent kidney stone formation through the…Read more

day: Day Two – Track A – 1